Table 1.
Descriptive statistics on patients and PAVMs
| Patient (n = 43) | |
|---|---|
| Age (years): mean ± SD | 42 ± 14 |
| Range | 19–71 |
| Sex (male: female ratio), n | 17/26 |
| Number of patients with HTT, n/N1 (%) | 23/43 |
| Presentation: n/N1 (%) | |
| Hypoxemia | 28/43 |
| Dyspnoea | 8/43 |
| Cyanosis | 7/43 |
| Cerebral abscess | 3/43 |
| Stroke | 2/43 |
| Migraine | 9/43 |
| Haemorrhage | 5/43 |
| PAVMs number (total): n/N1 (%) | |
| Single | 15/43 |
| Double | 12/43 |
| More than two | 16/43 |
| PAVMs location: n/N2 (%) | |
| Right upper lobe | 9/101 |
| Right middle lobe | 20/101 |
| Right lower lobe | 33/101 |
| Left upper lobe | 8/101 |
| Left lower lobe | 31/101 |
| Treated PAVMs number (N3/N2) | 72/101 |
| Treated PAVMs feeding artery (mm) | 7.9 ± 2.9 |
| Range | 3.5–14.0 mm |
| Embolization materials: n/N3 (%) | |
| Coil | 25/72 |
| Vascular plug | 21/72 |
| Coil and vascular plug | 26/72 |
| Complications: n/ N1 (%) | |
| Pleuritic chest pain | 5/43 |
| Pulmonary thrombosis and embolism | 1/43 |
| Follow-up period (months): mean ± SD | 25.02 ± 9.44 |
| Range | 12–49 |
HTT hereditary haemorrhagic telangiectasia, PAVM pulmonary arteriovenous malformation